Eglenen-Polat, Buse
Kowash, Ryan R.
Huang, Hai-Cheng
Siteni, Silvia
Zhu, Mingrui
Chen, Kenian http://orcid.org/0000-0002-4083-841X
Bender, Matthew E. http://orcid.org/0009-0005-7991-2460
Mender, Ilgen
Stastny, Victor
Drapkin, Benjamin J.
Raj, Prithvi
Minna, John D. http://orcid.org/0000-0002-7776-0767
Xu, Lin http://orcid.org/0000-0001-5815-4457
Shay, Jerry W. http://orcid.org/0000-0001-5052-0627
Akbay, Esra A. http://orcid.org/0000-0002-4149-2529
Funding for this research was provided by:
American Cancer Society (RSG-22-051-01-IBCD)
Cancer Prevention and Research Institute of Texas (RR160080)
A Breath of Hope Lung Foundation (ABOHLF 2020)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P50CA070907)
Article History
Received: 28 March 2023
Accepted: 6 January 2024
First Online: 22 January 2024
Competing interests
: I.M., S.S. and J.W.S. are named inventors on patents licensed to MAIA (16/450,430; 62,636,775; 62/646,820; 16/304,538; 17/200,539; 63/388,688). J.W.S. is on the SAB of MAIA Biotechnology. I.M. is currently at Maia Biotechnology Inc, Chicago, Illinois, USA. J.D.M. receives licensing fees from the NCI and UT Southwestern to distribute cell lines. B.J.D. has consulting agreements with Astra Zeneca, Sonata Therapeutics and Dialectic Therapeutics. Other authors declare no relevant conflicts of interests.